Table 1.
Protease/Inhibitor | Compound | Space Group | Cell Dimensions | Morphology | Crystallization Conditions | Flaps | Resolution Data Source |
---|---|---|---|---|---|---|---|
NL4-3 TL-3 (3KFR) |
1F1 | P212121 | 28.72 65.57 92.36 |
Blocks | 0.5 M KSCN, 0.1 M MES- HCL, pH 5.8, 10% DMSO | Closed | 1.3 Å SRRLa |
NL4-3 pepstatin (4EJD) |
1F1 | P212121 | 28.82 65.63 92.93 |
Blocks | 0.2 M KBr, 0.2M KSCN, 0.1M NaCacodylate pH 6.5, 3% PGA-LM, 10% DMSO, 3% MPD | Closed | 1.1 Å SSRL |
AR-PR (apo) (4EJ8) |
1F1 | P212121 | 28.95 66.53 91.71 |
Long needles | 0.1M Tris pH 7.5, 28% PEG 4K, 10% DMSO | Invertedb | 2.5 Å Bruker |
NL4-3 pepstatin (4EJK) |
1F1-N | P212121 | 28.65 65.79 92.05 |
Rods | 1.0 M NaFormate, 0.1 M NaOAc pH 4.6, 10% DMSO | Closed | 1.8 Å Bruker |
AR-PR (apo) (4EJL) |
1F1-N | P212121 | 28.82 65.91 92.51 |
Small rods | 0.8 M NaFormate, 0.1 M NaOAc pH 5.5, 15% PEG4K | Closed | 2.0 Å Bruker |
Reference (16)
Inverted = closed conformation of the flaps with reversed “handedness”